Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Schwartz

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
BJU International|September 16, 2010
Controversial technology: the Chunnel and the laparoscopic retroperitoneal lymph node dissection (RPLND)Michael J Schwartz, Louis R Kavoussi
Anesthesia and Analgesia|June 15, 2017
A Hospital Is Not Just a Factory, but a Complex Adaptive System-Implications for Perioperative CareAman Mahajan, Salim D Islam, Michael J Schwartz, et al.
Journal of Oncology|April 7, 2012
Toll-like receptor 7 agonist therapy with imidazoquinoline enhances cancer cell death and increases lymphocytic infiltration and proinflammatory cytokine production in established tumors of a renal cell carcinoma mouse modelEric C Kauffman, Huixian Liu, Michael J Schwartz, et al.
BJU International|February 5, 2008
Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinomaHuixian Liu, Michael J Schwartz, David H Hwang, et al.
Urology|July 25, 2009
Pelvic cake kidney with a solitary ureter and bilateral congenital absence of the vas deferensMichael J Schwartz, Roger Bartolotta, Paula W Brill, et al.
BJU International|December 15, 2006
Renal artery embolization: clinical indications and experience from over 100 casesMichael J Schwartz, Eric B Smith, David W Trost, et al.
Annals of Translational Medicine|February 10, 2023
Narrative review-focal therapy: are we ready to change the prostate cancer treatment paradigm?Thomas R Williams, Tavya G R Benjamin, Michael J Schwartz, et al.
Urology|January 3, 2009
Antitumor effects of an imidazoquinoline in renal cell carcinomaMichael J Schwartz, Huixian Liu, David H Hwang, et al.
Annals of Surgery|June 22, 2010
Eye metrics as an objective assessment of surgical skillLee Richstone, Michael J Schwartz, Casey Seideman, et al.
Current Opinion in Urology|May 13, 2022
Alternatives to whole gland treatment for localized prostate cancer: a review of novel focal therapiesTavya G R Benjamin, Thomas R Williams, Bertie Zhang, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
BJU International|September 16, 2010
Controversial technology: the Chunnel and the laparoscopic retroperitoneal lymph node dissection (RPLND)Michael J Schwartz, Louis R Kavoussi
Anesthesia and Analgesia|June 15, 2017
A Hospital Is Not Just a Factory, but a Complex Adaptive System-Implications for Perioperative CareAman Mahajan, Salim D Islam, Michael J Schwartz, et al.
Journal of Oncology|April 7, 2012
Toll-like receptor 7 agonist therapy with imidazoquinoline enhances cancer cell death and increases lymphocytic infiltration and proinflammatory cytokine production in established tumors of a renal cell carcinoma mouse modelEric C Kauffman, Huixian Liu, Michael J Schwartz, et al.
BJU International|February 5, 2008
Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinomaHuixian Liu, Michael J Schwartz, David H Hwang, et al.
Urology|July 25, 2009
Pelvic cake kidney with a solitary ureter and bilateral congenital absence of the vas deferensMichael J Schwartz, Roger Bartolotta, Paula W Brill, et al.
BJU International|December 15, 2006
Renal artery embolization: clinical indications and experience from over 100 casesMichael J Schwartz, Eric B Smith, David W Trost, et al.
Annals of Translational Medicine|February 10, 2023
Narrative review-focal therapy: are we ready to change the prostate cancer treatment paradigm?Thomas R Williams, Tavya G R Benjamin, Michael J Schwartz, et al.
Urology|January 3, 2009
Antitumor effects of an imidazoquinoline in renal cell carcinomaMichael J Schwartz, Huixian Liu, David H Hwang, et al.
Annals of Surgery|June 22, 2010
Eye metrics as an objective assessment of surgical skillLee Richstone, Michael J Schwartz, Casey Seideman, et al.
Current Opinion in Urology|May 13, 2022
Alternatives to whole gland treatment for localized prostate cancer: a review of novel focal therapiesTavya G R Benjamin, Thomas R Williams, Bertie Zhang, et al.
Pageof 3